Idbiologics, Inc
IDBiologics, Inc., based in Nashville, TN, is dedicated to the discovery and development of human monoclonal antibodies (mAbs) aimed at preventing and treating infectious diseases. Founded from the innovative research of Professor James Crowe at Vanderbilt University Medical Center, the company utilizes a leading-edge platform to create broad and potent therapeutic mAbs with neutralizing capabilities against various viral targets.
With a diverse pipeline that includes six clinical lead candidate molecules, IDBiologics showcases an extensive array of therapeutic antibodies for infectious diseases, each backed by robust animal proof of concept. Recently, the company announced a contract with the Department of Defense to further develop antibody medicines addressing infectious disease threats.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2024. All rights reserved.

